Developing lung cancer post-diagnosis system using pervasive data analytic framework

The data from lung cancer patients using wearable sensors and clinical assessments after observation is available to predict the disease’s recurrence. In recurrence prediction, pervasive data analysis is required to prevent flaws in clinical correlations and data observations. This article proposes...

Full description

Saved in:
Bibliographic Details
Main Authors: Pethuraj, Mohamed Shakeel, Mohd Aboobaider, Burhanuddin, Salahuddin, Lizawati
Format: Article
Language:English
Published: Elsevier Ltd. 2023
Online Access:http://eprints.utem.edu.my/id/eprint/27371/2/0102922062023.PDF
http://eprints.utem.edu.my/id/eprint/27371/
https://www.sciencedirect.com/science/article/pii/S0045790622007431
https://www.sciencedirect.com/science/article/pii/S0045790622007431
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The data from lung cancer patients using wearable sensors and clinical assessments after observation is available to predict the disease’s recurrence. In recurrence prediction, pervasive data analysis is required to prevent flaws in clinical correlations and data observations. This article proposes a Pervasive Data Analytical Framework (PDAF) for recurrence prediction. The proposed framework incorporates three processes: data segregation using Butterfly Optimisation, feature correlation using Jaya Optimisation, and autoencoder prediction. First, the data from the wearable sensor is segregated using observation count for its availability and discreteness. It prevents missing errors under different observation sequences for which the correlation rate is determined using the next optimization. In the Jaya optimization process, the features correlate with the clinical assessments to improve precision. The autoencoder predicts the occurrence of previous missing and non-correlated inputs for maximizing the detection rate. Using the proposed framework, the maximum gains of 9.22% in accuracy, 9.29% in detection, and 7.96% in recommendations.